![]() |
|
|
Vol. 282, Issue 2, 779-786, 1997
Centre for Pharmaceutical Research, The influence of experimentally induced renal failure on the
disposition of morphine, morphine-3-glucuronide (M3G) and
morphine-6-glucuronide (M6G) was examined in seven sheep infused
intravenously with morphine for 6 hr. Between 5 and 6 hr, blood was
collected from the aorta, pulmonary artery, hepatic, hepatic portal and
renal veins and posterior vena cava. Additional samples from the aorta
and urine were collected up to 144 hr. Morphine, M3G and M6G were
determined in plasma and urine by high-performance liquid
chromatography. Constant concentrations of morphine, but not of M3G and
M6G, were achieved in plasma between 5 and 6 hr. Significant (P < .001) extraction of morphine by the liver (0.72 ± 0.05) and
kidney (0.42 ± 0.15) occurred. Compared with sheep with normal
kidneys (), renal failure did not alter
(P = .11) the mean total clearance of morphine (1.5 ± 0.3 liters/min); clearance by the kidney was less (P < .001).
However, a paired comparison using sheep common to this study and from
the study when their kidneys were normal revealed a significant
reduction in mean total clearance of 25%. The renal extraction of M3G
and M6G and urinary recovery of the dose as summed morphine, M3G and
M6G were reduced by renal failure. The kidney metabolized morphine to
M3G. The data suggest that nonrenal elimination of M3G becomes more
important during renal failure.
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
N. J. Bouwmeester, B. J. Anderson, D. Tibboel, and N. H. G. Holford Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children Br. J. Anaesth., February 1, 2004; 92(2): 208 - 217. [Abstract] [Full Text] [PDF] |
||||